• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Exceptional activity of sub-nm Pt clusters on CdS for photocatalytic hydrogen production: a combined experimental and first-principles study?
  Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
• 3. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615
• 4. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 5. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583

• Solvents and Organic Chemicals Organic Compounds Benzenoids Indenes and isoindenes Indenes and isoindenes
• Solvents and Organic Chemicals Organic Compounds Benzenoids Indenes and isoindenes

Recent Advances in the Study of 1H-Indene-2-carboxylic acid (CAS: 41712-14-5) in Chemical Biology and Pharmaceutical Research

The compound 1H-Indene-2-carboxylic acid (CAS: 41712-14-5) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile chemical structure and potential therapeutic applications. This research brief aims to provide an overview of the latest studies involving this compound, highlighting its synthesis, biological activities, and potential as a drug candidate.

Recent studies have demonstrated that 1H-Indene-2-carboxylic acid serves as a key intermediate in the synthesis of various biologically active molecules. Its unique indene scaffold allows for modifications that can enhance its pharmacological properties. Researchers have explored its role in inhibiting specific enzymes involved in inflammatory pathways, making it a promising candidate for the development of anti-inflammatory drugs.

One of the groundbreaking studies published in 2023 utilized computational chemistry and molecular docking techniques to investigate the binding affinity of 1H-Indene-2-carboxylic acid with cyclooxygenase-2 (COX-2), a well-known target for anti-inflammatory drugs. The results indicated a strong interaction, suggesting its potential as a COX-2 inhibitor with fewer side effects compared to traditional nonsteroidal anti-inflammatory drugs (NSAIDs).

In addition to its anti-inflammatory properties, 1H-Indene-2-carboxylic acid has also been studied for its potential anticancer effects. A recent in vitro study demonstrated its ability to induce apoptosis in certain cancer cell lines by modulating the expression of pro-apoptotic proteins. These findings open new avenues for the development of novel anticancer therapies based on this compound.

Another area of interest is the compound's role in neurodegenerative diseases. Preliminary studies have shown that 1H-Indene-2-carboxylic acid can cross the blood-brain barrier and exhibit neuroprotective effects in models of Alzheimer's disease. Researchers are currently investigating its mechanism of action, with a focus on its ability to reduce oxidative stress and amyloid-beta aggregation.

The synthesis and optimization of 1H-Indene-2-carboxylic acid derivatives have also been a focal point of recent research. Advances in green chemistry have enabled more efficient and environmentally friendly synthesis routes, reducing the use of hazardous reagents and improving yields. These developments are crucial for scaling up production for preclinical and clinical studies.

Despite these promising findings, challenges remain in the development of 1H-Indene-2-carboxylic acid as a therapeutic agent. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through further research. Ongoing studies are focusing on structural modifications to enhance its pharmacokinetic properties while maintaining its biological activity.

In conclusion, 1H-Indene-2-carboxylic acid (CAS: 41712-14-5) represents a compound of significant interest in chemical biology and pharmaceutical research. Its diverse biological activities and potential therapeutic applications make it a valuable candidate for further investigation. Future research should focus on elucidating its mechanisms of action, optimizing its pharmacological properties, and advancing it through the drug development pipeline.

• 139398-11-1(2-Butenedioic acid, 2-[(2-methylphenyl)methyl]-, (E)-)
• 106167-47-9(Ethyl 1h-indene-2-carboxylate)
• 7316-64-5(1H-Indene-2-carboxylic acid, 3-methyl-, methyl ester)
• 34225-81-5(3-Methylindene-2-carboxylicacid)
• 76964-14-2(2-Naphthalenecarboxylic acid, 3,4-dihydro-5,8-dimethyl-)
• 14209-41-7(1H-Indene-3-carboxylic acid)
• 17332-04-6(1H-Indene-2-carboxylic acid, methyl ester)
• 4361-83-5((2E)-2-benzyl-3-phenylprop-2-enoic acid)
• 66130-41-4(1-methyl-1H-indene-2-carboxylic acid)
• 6279-88-5(1-methyl-3,4-dihydronaphthalene-2-carboxylic acid)